Pre-Market Activity Shows Heavy Volume And Movement For Novartis (NVS)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Novartis ( NVS) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Novartis as such a stock due to the following factors:

  • NVS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $76.0 million.
  • NVS traded 1.1 million shares today in the pre-market hours as of 8:35 AM, representing 123.4% of its average daily volume.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in NVS with the Ticky from Trade-Ideas. See the FREE profile for NVS NOW at Trade-Ideas

More details on NVS:

Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism. The stock currently has a dividend yield of 2.7%. NVS has a PE ratio of 23.6. Currently there are 4 analysts that rate Novartis a buy, 1 analyst rates it a sell, and 3 rate it a hold.

The average volume for Novartis has been 1.1 million shares per day over the past 30 days. Novartis has a market cap of $212.3 billion and is part of the health care sector and drugs industry. Shares are up 10.3% year-to-date as of the close of trading on Tuesday.

If you liked this article you might like

Novartis CEO Joe Jimenez to Step Down in 2018

FDA Greenlights Novartis' Gene Therapy for Leukemia

Novartis' CAR-T Gene Therapy Receives FDA Approval

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)